Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines - Liu, Yi; Sánchez-Ovando, Stephany; Carolan, Louise; Dowson, Leslie; Khvorov, Arseniy; Jessica Hadiprodjo, A.; Tseng, Yeu Yang; Delahunty, Catherine; Khatami, Ameneh; Macnish, Marion; Dougherty, Sonia; Hagenauer, Michelle; et al. (Vaccine, 2023)
Keywords: Adenoviruses; Allergy and Immunology; Antibodies; Antibodies, Viral; Antibody; B cells; B-lymphocytes; BNT162 Vaccine; ChAdOx1 nCoV-19; COVID-19; COVID-19 - prevention & control; COVID-19 infection; COVID-19 Vaccines; Disease transmission; Fluorescence; health services; Hospitals; Human mastadenovirus C; Humans; Immunity; Immunogenicity; Immunoglobulin G; Immunological memory; Infections; Influenza; Lymphocytes B; Medical personnel; memory; Memory cells; Monkeys & apes; mRNA; mRNA vaccines; Neutralization; neutralization tests; pandemic; Pandemics; Pandemics - prevention & control; Performance evaluation; Protein folding; Proteins; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; vaccination; Vaccine; Vaccines; Vector; Viral diseases; Viral Vaccines; Australia; COVID-19; SARS-CoV-2; Antibody; Vaccine; mRNA; B cells; Vector